
Ana Belen
Articles
-
2 weeks ago |
dialnet.unirioja.es | Antonio Martinez |Antonio Martínez |Madrigal Martínez |Fernandez Martinez |Ana Belen
Ayuda Buscar en la ayuda Buscar en la ayuda Implicación de la prostaglandina E2 intracelular en el desarrollo de la hiperplasia prostática benigna Madrigal Martínez, Antonio [1] ; Fernández Martínez, Ana Belen [1] ; Lucio Cazaña, Javier de [1] [1] Universidad de Alcalá Alcalá de Henares, España Localización: Dianas: revista de dianas terapéuticas, ISSN-e 1886-8746, Vol.
-
2 months ago |
academic.oup.com | Servicio de Microbiología |Ciudad Real |Francisco Javier |Ana Belen
Gut colonization by multidrug resistant (MDR) microorganisms including extended spectrum beta lactamase (ESBL)-producing Enterobacteriaceae is not an infrequent event in environments apart from hospitals; in fact, a global spread into the community has been documented with current prevalence rates of 17% of faecal colonization in healthy individuals.1 There are no local data on gut colonization prevalence in healthy people in the community, but according to EARSS...
-
Nov 28, 2024 |
dialnet.unirioja.es | Ana Blanco |Maria Sanchez |María Sanchez |María Sánchez |Ana Belen |María Soledad
IdiomacatalàDeutschEnglishespañoleuskarafrançaisgalegoitalianoportuguêsromână
-
Nov 20, 2024 |
ejnmmires.springeropen.com | Juan Pedro |Jose Luis |Ana Belen |Maria Jose
A total of 103 consecutive patients with R/R B-cell lymphoma were treated with CAR-T therapy in Centre 1 and Centre 2 during the inclusion period (Fig. 1). Among them, 33 patients were excluded as due to the lack of availability of [18F]FDG PET/CT scan acquired before CAR-T cell infusion. Therefore, 70 patients were eligible for inclusion as they had a [18F]FDG PET/CT scan acquired before CAR-T cell infusion that passed the quality check.
-
Nov 5, 2024 |
dialnet.unirioja.es | Valverde Cano |Ana Belen
IdiomacatalàDeutschEnglishespañoleuskarafrançaisgalegoitalianoportuguêsromână
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →